AAAAAA

   
Results: 1-9 |
Results: 9
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression
Authors: Sabbe, R Picchio, GR Pastore, C Chaloin, O Hartley, O Offord, R Mosier, DE
Citation: R. Sabbe et al., Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression, J VIROLOGY, 75(2), 2001, pp. 661-671
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy
Authors: Picchio, GR Valdez, H Sabbe, R Landay, AL Kuritzkes, DR Lederman, MM Mosier, DE
Citation: Gr. Picchio et al., Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy, J ACQ IMM D, 25(4), 2000, pp. 289-295
Virus and target cell evolution in human immunodeficiency virus type 1 infection
Authors: Mosier, DE
Citation: De. Mosier, Virus and target cell evolution in human immunodeficiency virus type 1 infection, IMMUNOL RES, 21(2-3), 2000, pp. 253-258
Human xenograft models for virus infection
Authors: Mosier, DE
Citation: De. Mosier, Human xenograft models for virus infection, VIROLOGY, 271(2), 2000, pp. 215-219
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in SCID mice
Authors: D'Agostino, G Arico, E Santodonato, L Venditti, M Sestili, P Masuelli, L Coletti, A Modesti, A Picchio, G Mosier, DE Ferrantini, M Belardelli, F
Citation: G. D'Agostino et al., Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in SCID mice, J INTERF CY, 19(11), 1999, pp. 1305-1316
Neutralizing antibodies have limited effects on the control of establishedHIV-1 infection in vivo
Authors: Poignard, P Sabbe, R Picchio, GR Wang, M Gulizia, RJ Katinger, H Parren, PWHI Mosier, DE Burtons, DR
Citation: P. Poignard et al., Neutralizing antibodies have limited effects on the control of establishedHIV-1 infection in vivo, IMMUNITY, 10(4), 1999, pp. 431-438
Transduction of human CD34(+) cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
Authors: Miyoshi, H Smith, KA Mosier, DE Verma, IM Torbett, BE
Citation: H. Miyoshi et al., Transduction of human CD34(+) cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors, SCIENCE, 283(5402), 1999, pp. 682-686
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
Authors: Mosier, DE Picchio, GR Gulizia, RJ Sabbe, R Poignard, P Picard, L Offord, RE Thompson, DA Wilken, J
Citation: De. Mosier et al., Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants, J VIROLOGY, 73(5), 1999, pp. 3544-3550
The antiviral activity of HIV-specific CD8(+) CTL clones is limited by elimination due to encounter with HIV-infected targets
Authors: McKinney, DM Lewinsohn, DA Riddell, SR Greenberg, PD Mosier, DE
Citation: Dm. Mckinney et al., The antiviral activity of HIV-specific CD8(+) CTL clones is limited by elimination due to encounter with HIV-infected targets, J IMMUNOL, 163(2), 1999, pp. 861-867
Risultati: 1-9 |